These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30779874)

  • 21. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stem cells.
    Wang Q; Chear S; Wing K; Stellon D; Nguyen Tran MT; Talbot J; Pébay A; Hewitt AW; Cook AL
    Methods; 2021 Oct; 194():18-29. PubMed ID: 33607266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted delivery of CRISPR-Cas9 ribonucleoprotein into arthropod ovaries for heritable germline gene editing.
    Chaverra-Rodriguez D; Macias VM; Hughes GL; Pujhari S; Suzuki Y; Peterson DR; Kim D; McKeand S; Rasgon JL
    Nat Commun; 2018 Aug; 9(1):3008. PubMed ID: 30068905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.
    Zetsche B; Heidenreich M; Mohanraju P; Fedorova I; Kneppers J; DeGennaro EM; Winblad N; Choudhury SR; Abudayyeh OO; Gootenberg JS; Wu WY; Scott DA; Severinov K; van der Oost J; Zhang F
    Nat Biotechnol; 2017 Jan; 35(1):31-34. PubMed ID: 27918548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
    Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The application of CRISPR/Cas9 in genome editing of filamentous fungi.
    Li HH; Liu G
    Yi Chuan; 2017 May; 39(5):355-367. PubMed ID: 28487268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could CRISPR be the solution for gene editing's Gordian knot?
    Fang H; Wang W
    Cell Biol Toxicol; 2016 Dec; 32(6):465-467. PubMed ID: 27614448
    [No Abstract]   [Full Text] [Related]  

  • 31. Liposomal delivery of CRISPR/Cas9.
    Zhen S; Li X
    Cancer Gene Ther; 2020 Aug; 27(7-8):515-527. PubMed ID: 31676843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-Cas9-mediated genome editing in apple and grapevine.
    Osakabe Y; Liang Z; Ren C; Nishitani C; Osakabe K; Wada M; Komori S; Malnoy M; Velasco R; Poli M; Jung MH; Koo OJ; Viola R; Nagamangala Kanchiswamy C
    Nat Protoc; 2018 Dec; 13(12):2844-2863. PubMed ID: 30390050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopeptide-Based Nanosome-Mediated Delivery of Hyperaccurate CRISPR/Cas9 Ribonucleoprotein for Gene Editing.
    Thach TT; Bae DH; Kim NH; Kang ES; Lee BS; Han K; Kwak M; Choi H; Nam J; Bae T; Suh M; Hur JK; Kim YH
    Small; 2019 Nov; 15(46):e1903172. PubMed ID: 31588686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells.
    Hultquist JF; Schumann K; Woo JM; Manganaro L; McGregor MJ; Doudna J; Simon V; Krogan NJ; Marson A
    Cell Rep; 2016 Oct; 17(5):1438-1452. PubMed ID: 27783955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
    Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.
    Chadwick AC; Musunuru K
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):12-18. PubMed ID: 28838920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery.
    Andersson M; Turesson H; Olsson N; Fält AS; Ohlsson P; Gonzalez MN; Samuelsson M; Hofvander P
    Physiol Plant; 2018 Dec; 164(4):378-384. PubMed ID: 29572864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
    Kuruvilla J; Sasmita AO; Ling APK
    Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.